Roles of PPARs in health and disease

被引：1608

作者：

Kersten, S ^{[1
]}

Desvergne, B ^{[1
]}

Wahli, W ^{[1
]}

机构：

[1] Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland

来源：

NATURE | 2000年 / 405卷 / 6785期

关键词：

D O I：

10.1038/35013000

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

In developed societies, chronic diseases such as diabetes, obesity, atherosclerosis and cancer are responsible for most deaths. These ailments have complex causes involving genetic, environmental and nutritional factors. There is evidence that a group of closely related nuclear receptors, called peroxisome proliferator-activated receptors (PPARs), may be involved in these diseases. This, together with the fact that PPAR activity can be modulated by drugs such as thiazolidinediones and fibrates, has instigated a huge research effort into PPARs(1). Here we present the latest developments in the PPAR field, with particular emphasis on the physiological function of PPARs during various nutritional states, and the possible role of PPARs in several chronic diseases.

引用

页码：421 / 424

页数：4

共 30 条

[1] PPARγ is required for placental, cardiac, and adipose tissue development
Barak, Y
Nelson, MC
Ong, ES
Jones, YZ
Ruiz-Lozano, P
Chien, KR
Koder, A
Evans, RM
[J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
[2] Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
Barroso, I
Gurnell, M
Crowley, VEF
Agostini, M
Schwabe, JW
Soos, MA
Maslen, GL
Williams, TDM
Lewis, H
Schafer, AJ
Chatterjee, VKK
O'Rahilly, S
[J]. NATURE, 1999, 402 (6764) : 880 - 883
[3] Peroxisome proliferator-activated receptor β regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures
Basu-Modak, S
Braissant, O
Escher, P
Desvergne, B
Honegger, P
Wahli, W
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) : 35881 - 35888
[4] Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1
Delerive, P
De Bosscher, K
Besnard, S
Vanden Berghe, W
Peters, JM
Gonzalez, FJ
Fruchart, JC
Tedgui, A
Haegeman, G
Staels, B
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32048 - 32054
[5] Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
Demetri, GD
Fletcher, CDM
Mueller, E
Sarraf, P
Naujoks, R
Campbell, N
Spiegelman, BM
Singer, S
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3951 - 3956
[6] Peroxisome proliferator-activated receptors: Nuclear control of metabolism
Desvergne, B
Wahli, W
[J]. ENDOCRINE REVIEWS, 1999, 20 (05) : 649 - 688
[7] Chemical probes that differentially modulate peroxisome proliferator-activated receptor α and BLTR, nuclear and cell surface receptors for leukotriene B4
Devchand, PR
Hihi, AK
Perroud, M
Schleuning, WDD
Spiegelman, BM
Wahli, W
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23341 - 23348
[8] Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2):: divergent modulating effects on body mass index in obese and lean Caucasian men
Ek, J
Urhammer, SA
Sorensen, TIA
Andersen, T
Auwerx, J
Pedersen, O
[J]. DIABETOLOGIA, 1999, 42 (07) : 892 - 895
[9] Phytanic acid activates the peroxisome proliferator-activated receptor α (PPARα) in sterol carrier protein 2- sterol carrier protein x-deficient mice
Ellinghaus, P
Wolfrum, C
Assmann, G
Spener, F
Seedorf, U
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) : 2766 - 2772
[10] Fajas L, 1999, MOL CELL BIOL, V19, P5495

← 1 2 3 →